Albert David Limited (NSE:ALBERTDAVD)
India · Delayed Price · Currency is INR 654.60
+38.40 (6.23%)
Apr 2, 2026, 3:30 PM IST
Albert David Market Cap
Albert David has a market cap or net worth of 3.73 billion as of April 2, 2026. Its market cap has decreased by -26.45% in one year.
Market Cap
3.73B
Enterprise Value
1.30B
Revenue
3.23B
Ranking
n/a
PE Ratio
38.78
Stock Price
654.60
Market Cap Chart
Since October 30, 2001, Albert David's market cap has increased from 80.47M to 3.73B, an increase of 4,532.27%. That is a compound annual growth rate of 17.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 3.51B | -17.00% |
| Dec 31, 2025 | 4.22B | -44.14% |
| Dec 31, 2024 | 7.56B | 35.71% |
| Dec 29, 2023 | 5.57B | 71.95% |
| Dec 30, 2022 | 3.24B | -6.10% |
| Dec 31, 2021 | 3.45B | 36.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beta Drugs | 12.82B |
| Jagsonpal Pharmaceuticals | 12.43B |
| Ind-Swift Laboratories | 11.98B |
| Sakar Healthcare | 11.47B |
| Sigachi Industries | 7.44B |
| Valiant Laboratories | 3.09B |
| Bafna Pharmaceuticals | 2.65B |
| Nectar Lifesciences | 1.90B |